Prediction tool for blood cancer therapies

prediction tool

Prediction tool developed to determine benefit of blood cancer treatment: Since its introduction in 2015, a prediction tool developed by the European Society of Medical Oncology (ESMO) has been providing support worldwide in the assessment of the clinical benefits of new cancer therapies. However, previously available versions proved unsuitable for use with malignant diseases of […]

Read More… from Prediction tool for blood cancer therapies

Eliminating the need for bone marrow donors

Can we eliminate the need for bone marrow donors? There is a chance that we can. At the moment, people who develop leukaemia, lymphoma and other blood diseases often need to undergo a hematopoietic stem cell transplantation (“HSCT”). This is because initial treatment of the disease (front-line therapy) often fails and the disease comes back. […]

Read More… from Eliminating the need for bone marrow donors